- CA$317.41m
- CA$261.03m
- CA$129.93m
- 74
- 42
- 92
- 79
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3.59 | 6.31 | 13.4 | 43.8 | 130 |
Cost of Revenue | |||||
Gross Profit | 1.19 | 0.091 | 0.125 | 1.5 | 25.9 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 16.8 | 21.6 | 30 | 62.7 | 134 |
Operating Profit | -13.2 | -15.3 | -16.5 | -18.9 | -4.57 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -13.4 | -23.9 | -26.3 | -21.4 | -2.87 |
Provision for Income Taxes | |||||
Net Income After Taxes | -13.4 | -23.9 | -26.3 | -21.4 | -2.94 |
Net Income Before Extraordinary Items | |||||
Net Income | -13.4 | -23.9 | -26.3 | -21.4 | -2.94 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -13.4 | -23.9 | -26.3 | -21.4 | -2.94 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.302 | -0.528 | -0.65 | -0.508 | -0.063 |
Dividends per Share |